Author(s):
Puneeth Raj R M, Shivani Koul, Vikas Mishra, Mohar Pal Meena, Reetesh Ramnani, Anupam Srivastava
Email(s):
puneethjayesh@gmail.com
DOI:
10.52711/0974-4150.2026.00070 
Address:
Puneeth Raj R M*1, Shivani Koul2, Vikas Mishra3, Mohar Pal Meena4, Reetesh Ramnani5, Anupam Srivastava6
1PG Scholar, Department of Rasa Shastra Evum Bhaishajya Kalpana, National Institute of Ayurveda Deemed University, Amer Rd, Jaipur, Rajasthan, India.
2PhD Scholar, Department of Rasa Shastra Evum Bhaishajya Kalpana, National Institute of Ayurveda Deemed University, Amer Rd, Jaipur, Rajasthan, India.
3PG Scholar, Department of Rasa Shastra Evum Bhaishajya Kalpana, National Institute of Ayurveda Deemed University, Amer Rd, Jaipur, Rajasthan, India.
4 Professor, Department of Rasa Shastra Evum Bhaishajya Kalpana, National Institute of Ayurveda Deemed University, Amer Rd, Jaipur, Rajasthan, India.
5Assistant Professor, Department of Rasa Shastra Evum Bhaishajya Kalpana, National Institute of Ayurveda Deemed University, Amer Rd, Jaipur, Rajasthan, India.
6Head of Department, Department of Rasa Shastra Evum Bhaishajya Kalpana, National Institute of Ayurveda Deemed University, A
Published In:
Volume - 19,
Issue - 5,
Year - 2026
ABSTRACT:
Background: Allergic asthma is a chronic inflammatory airway disease characterized by reversible airflow obstruction, bronchial hyper-responsiveness, and immune dysregulation involving immunoglobulin E (IgE), eosinophils, and T-helper 2 (Th2) cytokines. Despite advances in conventional therapy, disease recurrence, adverse drug effects, and incomplete symptom control remain major challenges. In Ayurveda, Tamaka Shwasa, a subtype of Shwasa Roga, closely resembles allergic asthma in its etiopathogenesis, clinical presentation, and chronic recurrent nature. Objective: To critically review the Ayurvedic concept of Tamaka Shwasa and correlate its etiopathogenesis, clinical manifestations, and management principles with the contemporary understanding of allergic asthma. Materials and Methods: A comprehensive narrative review was conducted using classical Ayurvedic texts, including the Charaka Samhita, Sushruta Samhita, and Ashtanga Hridaya, along with contemporary peer-reviewed literature on allergic asthma. Classical concepts were critically compared with modern evidence to identify conceptual and pathophysiological correlations. Results: The classical description of Tamaka Shwasa shows several clinically relevant similarities to allergic asthma, including recurrent dyspnoea, wheezing, cough, mucus-associated obstruction, nocturnal aggravation, environmental trigger sensitivity, and a chronic relapsing course. Concepts such as Kapha-induced Srotorodha and Pratiloma Gati of Pra?a Vayu may provide interpretative frameworks for understanding airway obstruction and disturbed respiratory function. However, terms such as Do?a, Agni, Ama, and Srotas have no established direct biomedical equivalents, and proposed correlations with airway inflammation, mucus hypersecretion, and immune dysregulation should be regarded as hypothesis-generating rather than biologically proven. Conclusion: Tamaka Shwasa demonstrates substantial clinical and functional similarities with allergic asthma. However, Ayurvedic concepts such as Do?a, Agni, Ama, and Srotas have no established direct biomedical equivalents. Integrative interpretation may generate useful research hypotheses, but further experimental and clinical studies are required before therapeutic conclusions or clinical recommendations can be made."
Cite this article:
Puneeth Raj R M, Shivani Koul, Vikas Mishra, Mohar Pal Meena, Reetesh Ramnani, Anupam Srivastava. Tamaka Shwasa and Allergic Asthma: A Critical Narrative Review of Classical Ayurvedic Concepts and Contemporary Biomedical Evidence. Asian Journal of Research in Chemistry. 2026; 19(5):478-0. doi: 10.52711/0974-4150.2026.00070
Cite(Electronic):
Puneeth Raj R M, Shivani Koul, Vikas Mishra, Mohar Pal Meena, Reetesh Ramnani, Anupam Srivastava. Tamaka Shwasa and Allergic Asthma: A Critical Narrative Review of Classical Ayurvedic Concepts and Contemporary Biomedical Evidence. Asian Journal of Research in Chemistry. 2026; 19(5):478-0. doi: 10.52711/0974-4150.2026.00070 Available on: https://www.ajrconline.org/AbstractView.aspx?PID=2026-19-5-11
REFERENCES:
1. Global Initiative for Asthma. Global strategy for asthma management and prevention: 2025 update. Fontana (WI): Global Initiative for Asthma; 2025.
2. World Health Organization. Asthma. Geneva: World Health Organization; 2024.
3. Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J, editors. Harrison’s Principles of Internal Medicine. 21st ed. New York: McGraw-Hill Education; 2022.
4. Agnivesha. Charaka Samhita, Chikitsa Sthana, Chapter 17. In: Acharya YT, editor. Charaka Samhita of Agnivesha with Ayurveda Dipika commentary of Chakrapanidatta. Reprint ed. Varanasi: Chaukhambha Surbharati Prakashan; 2020.
5. Kumar V, Abbas AK, Aster JC. Robbins and Cotran pathologic basis of disease. 11th ed. Philadelphia: Elsevier; 2021.
6. Vagbhata. Ashtanga Hridaya, Nidana Sthana, Chapter 4. In: Harisastri Paradakara V, editor. Reprint ed. Varanasi: Chaukhambha Orientalia; 2022.
7. Sushruta. Sushruta Samhita, Uttara Tantra, Chapter 51, with Nibandha Sangraha commentary of Dalhana. In: Acharya YT, editor. Reprint ed. Varanasi: Chaukhambha Surbharati Prakashan; 2020.
8. Monier-Williams M. A Sanskrit-English dictionary. Reprint ed. New Delhi: Motilal Banarsidass Publishers; 2005.
9. Sharma RK, Dash B. Charaka Samhita of Agnivesa. Vol. 5, Chikitsa Sthana. Varanasi: Chowkhamba Sanskrit Series Office; 2013.
10. Srikantha Murthy KR. Ashtanga Hridayam of Vagbhata. Vol. 2. Varanasi: Chaukhambha Krishnadas Academy; 2019.
11. Tripathi B. Madhava Nidana of Madhavakara. Varanasi: Chaukhambha Surbharati Prakashan; 2019.
12. Sharma PV. Dravyaguna Vijnana. Vol. 2. Varanasi: Chaukhambha Bharati Academy; 2020.
13. Mishra BS, Vaishya R. Bhavaprakasha of Bhavamishra. Varanasi: Chaukhambha Sanskrit Bhawan; 2020.
14. Papi A, Brightling C, Pedersen SE, Reddel HK. Asthma. Lancet. 2018;391(10122):783–800.
15. GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability, disability-adjusted life-years, and healthy life expectancy for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2133–2161.
16. Pawankar R, Canonica GW, Holgate ST, Lockey RF, Blaiss MS, editors. WAO white book on allergy: update 2013. Milwaukee (WI): World Allergy Organization; 2013.
17. Lambrecht BN, Hammad H. The immunology of asthma. Nat Immunol. 2015;16(1):45–56.
18. Holgate ST. Pathogenesis of asthma. Clin Exp Allergy. 2008;38(6):872–897.
19. Global Initiative for Asthma. Difficult-to-treat and severe asthma in adolescent and adult patients: diagnosis and management. Fontana (WI): Global Initiative for Asthma; 2024.
20. Busse WW, Lemanske RF Jr. Asthma. N Engl J Med. 2001;344(5):350–362.
21. Barnes PJ. Asthma mechanisms. Medicine (Abingdon). 2023;51(4):231–238.
22. Holgate ST, Wenzel S, Postma DS, Weiss ST, Renz H, Sly PD. Asthma. Nat Rev Dis Primers. 2015; 1:15025.
23. Dharmage SC, Perret JL, Custovic A. Epidemiology of asthma in children and adults. Front Pediatr. 2019; 7:246.
24. Akdis CA, Arkwright PD, Brüggen MC, et al. Type 2 immunity in asthma and allergy. Nat Rev Immunol. 2020;20(2):114–130.
25. Masoli M, Fabian D, Holt S, Beasley R; Global Initiative for Asthma Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004;59(5):469–478.
26. Patwardhan B, Vaidya ADB, Chorghade M. Ayurveda and natural products drug discovery. Curr Sci. 2004;86(6):789–799.
27. Patwardhan B, Mutalik G, Tillu G. Integrative approaches for health: biomedical research, Ayurveda and yoga. London: Academic Press; 2015.
28. Dhuley JN. Antitussive effect of Adhatoda vasica extract on mechanical or chemical stimulation-induced coughing in animals. J Ethnopharmacol. 1999;67(3):361–365.
29. Claeson UP, Malmfors T, Wikman G, Bruhn JG. Adhatoda vasica: a critical review of ethnopharmacological and toxicological data. J Ethnopharmacol. 2000;72(1–2):1–20.
30. Manarin G, Anderson D, Silva JME, Coppede JS, Roxo-Junior P, Pereira AMS, et al. Curcuma longa L. ameliorates asthma control in children and adolescents: a randomized, double-blind, controlled trial. J Ethnopharmacol. 2019; 238: 111882.
31. Ahui MLB, Champy P, Ramadan A, Pham Van L, Araujo L, Brou André K, et al. Ginger prevents Th2-mediated immune responses in a mouse model of airway inflammation. Int Immunopharmacol. 2008;8(12):1626–1632.
32. Tiwari M, Dwivedi UN, Kakkar P. Tinospora cordifolia extract modulates COX-2, iNOS, ICAM-1, pro-inflammatory cytokines and redox status in a murine model of asthma. J Ethnopharmacol. 2014;153(2):326–337.
33. Singh BB, Khorsan R, Vinjamury SP, Der-Martirosian C, Kizhakkeveettil A, Anderson TM. Herbal treatments of asthma: a systematic review. J Asthma. 2007;44(9):685–698.
34. Yugandhar P, Rao KM, Sengupta K. A novel herbal composition containing extracts of Boswellia serrata gum resin and Aegle marmelos fruit alleviates symptoms of asthma in a placebo-controlled double-blind clinical study. Phytother Res. 2018;32(1):140–150.
35. Derakhshan A, Sadeghi M, Asnaashari AMH, Dehghani M, Salari R, Khadem-Rezaiyan M, et al. Efficacy of herbal medicines on lung function in asthma: a systematic review and meta-analysis of randomized controlled trials. J Pharmacopuncture. 2023; 26(2): 124–138.
36. Agustí A, Bafadhel M, Beasley R, Bel EH, Faner R, Gibson PG, et al. Precision medicine in airway diseases: moving to clinical practice. Eur Respir J. 2017; 50(4): 1701655.
37. Pavord ID, Beasley R, Agustí A, Anderson GP, Bel E, Brusselle G, et al. After asthma: redefining airways diseases. Lancet. 2018;391(10118):350–400.
38. Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol. 2014; 5:177.
39. Tilburt JC, Kaptchuk TJ. Herbal medicine research and global health: an ethical analysis. Bull World Health Organ. 2008; 86(8): 594–599.
40. Labiris NR, Dolovich MB. Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol. 2003; 56(6): 588–599.
41. Patwardhan B, Vaidya ADB. Chasing the dreams of integrative medicine. J Ayurveda Integr Med. 2010; 1(2): 91–99.
42. World Health Organization. Global traditional medicine strategy 2025–2034. Geneva: World Health Organization; 2025.
43. Patwardhan B, Chandran U. Network ethnopharmacology and systems Ayurveda: future directions for traditional medicine research. J Ayurveda Integr Med. 2015;6(2):73–74.
44. Chan AW, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013; 158(3): 200–207.
45. Newman SP. Drug delivery to the lungs: challenges and opportunities. Ther Deliv. 2017; 8(8): 647–661.
46. Fasinu PS, Bouic PJD, Rosenkranz B. An overview of the evidence and mechanisms of herb–drug interactions. Front Pharmacol. 2012; 3: 69.